yttrium radioisotopes has been researched along with Malignant Melanoma in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.34) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 18 (62.07) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Bertaglia, V; Luciani, A; Pearce, J; Petrelli, F; Porcu, M; Saba, L; Scartozzi, M; Solinas, C | 1 |
| Bercu, ZL; Elsayed, M; Ermentrout, RM; Kokabi, N; Kudchadkar, RR; Lawson, DH; Levey, AO; Newsome, J; Yushak, ML | 1 |
| Andrews, MC; Arulananda, S; Cebon, J; Goodwin, M; Palmer, J; Parakh, S | 1 |
| Albertini, MR; Aluicio-Sarduy, E; Bednarz, B; Engle, JW; Esbona, K; Grudzinski, J; Hernandez, R; Jaskowiak, C; Kurzman, ID; Magee, K; Marsh, IR; Morris, ZS; Oseid, EA; Sondel, PM; Turek, MM; Vail, DM; Weichert, JP; Zuleger, CL | 1 |
| Jia, Z; Jiang, G; Li, S; Qin, X; Wang, K; Zhu, C | 1 |
| Arellano, RS; Flaherty, K; Irani, Z; Lawrence, D; Zheng, J | 1 |
| Padia, SA | 1 |
| Abbott, AM; Choi, J; Doepker, MP; Gandle, C; Kim, Y; Perez, MC; Shridhar, R; Thomas, KL; Zager, JS | 1 |
| Adamo, RD; Anne, PR; Chervoneva, I; Eschelman, DJ; Gonsalves, CF; Hage, AN; Orloff, MM; Sato, T; Terai, M; Yi, M | 1 |
| Deroose, C; Maleux, G; Vanslembrouck, R; Wolter, P | 1 |
| Barron, B; Eaton, BR; Fox, T; Galt, JR; Kim, HS; Kim, S; Landry, J; Liu, Y; Schreibmann, E; Schuster, DM | 1 |
| Anne, PR; Bar-Ad, V; Dicker, A; Doyle, L; Eldredge-Hindy, H; Eschelman, D; Gonsalves, C; Intenzo, C; Li, J; Ohri, N; Sato, T | 1 |
| Atassi, R; Kuzel, TM; Lewandowski, RJ; Memon, K; Salem, R; Vouche, M | 1 |
| Dhanasekaran, R; Eaton, BR; Kim, HS; Kokabi, N; Lawson, DH; Prajapati, HJ; Xing, M | 1 |
| Arellano, RS; Irani, Z; Kwok, N; Sheth, R | 1 |
| Bartlett, DL; Chung, MH; Doherty, MG; Marsh, JW; Varma, MK; Wright, GP | 1 |
| Beny, A; Cianni, R; Dezarn, WA; Jakobs, T; Kennedy, AS; Notarianni, E; Nutting, C; Ofer, A | 1 |
| Brechbiel, MW; Clifford, T; Gallazzi, F; Jin, X; Lewis, JS; Miao, Y; Quinn, TP; Wei, L; Welch, MJ; Xu, H; Zhang, X | 1 |
| Ellis, S; Hahl, M; Martin, RC; McMasters, K; Scoggins, CR; Tatum, C; Whitney, R | 1 |
| Coldwell, D; Kennedy, A; Salem, R; Sangro, B; Wasan, H | 1 |
| Hoffmann, RT; Jakobs, TF; Paprottka, P; Reiser, MF; Trumm, CG | 1 |
| Haug, AR; Klingenstein, A; Schaller, UC; Zech, CJ | 1 |
| Barron, BJ; Dhanasekaran, R; Kim, HS; Lawson, DH; Piduru, SM; Schuster, DM | 1 |
| Fisher, DR; Miao, Y; Quinn, TP | 1 |
| Becker, M; Brod, KH; Dähnert, W; Grimm, W; Kutzner, J; Schreyer, T | 1 |
| Brovkina, AF; Dedenkov, AN; Vakulenko, MP; Zarubeĭ, GD | 1 |
| Buchsbaum, DJ; Heidorn, DB; Lawrence, TS; Roberson, PL; Steplewski, Z; Ten Haken, RK | 1 |
| Lommatzsch, PK | 1 |
| Edwards, JA; Klein, JL; Kopher, KA; Order, SE; Wanek, PM; Wessels, BW; Wharam, MD; Williams, JA | 1 |
5 review(s) available for yttrium radioisotopes and Malignant Melanoma
| Article | Year |
|---|---|
Assessment of clinical studies evaluating combinations of immune checkpoint inhibitors with locoregional treatments in solid tumors.
Topics: Carcinoma, Hepatocellular; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Liver Neoplasms; Melanoma; Yttrium Radioisotopes | 2022 |
A systematic review of yttrium-90 radioembolization for unresectable liver metastases of melanoma.
Topics: Abdominal Pain; Aged; Brachytherapy; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Nausea; Radiopharmaceuticals; Skin Neoplasms; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Y90 Clinical Data Update: Cholangiocarcinoma, Neuroendocrine Tumor, Melanoma, and Breast Cancer Metastatic Disease.
Topics: Breast Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Melanoma; Microspheres; Neuroendocrine Tumors; Radiography, Interventional; Yttrium Radioisotopes | 2019 |
Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Glass; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Microspheres; Resins, Synthetic; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2012 |
Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
Topics: Antineoplastic Agents; Breast Neoplasms; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Melanoma; Microspheres; Neuroendocrine Tumors; Pancreatic Neoplasms; Yttrium Radioisotopes | 2011 |
3 trial(s) available for yttrium radioisotopes and Malignant Melanoma
| Article | Year |
|---|---|
A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases.
Topics: Aged; Chemoradiotherapy; Cisplatin; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Male; Melanoma; Middle Aged; Pilot Projects; Progression-Free Survival; Uveal Neoplasms; Yttrium Radioisotopes | 2019 |
A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
Topics: Diagnostic Imaging; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2019 |
Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
21 other study(ies) available for yttrium radioisotopes and Malignant Melanoma
| Article | Year |
|---|---|
Predictors of Overall and Progression-Free Survival in Patients with Ocular Melanoma Metastatic to the Liver Undergoing Y90 Radioembolization.
Topics: Brachytherapy; Combined Modality Therapy; Eye Neoplasms; Female; Humans; Immunotherapy; Kaplan-Meier Estimate; Liver Neoplasms; Male; Melanoma; Middle Aged; Progression-Free Survival; Retrospective Studies; Yttrium Radioisotopes | 2020 |
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Combined Modality Therapy; Dogs; Feasibility Studies; Female; Gene Expression; Interleukin-2; Leukocytes, Mononuclear; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vaccination; Yttrium Radioisotopes | 2021 |
Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Immunotherapy; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Preliminary Data; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors; Uveal Neoplasms; Yttrium Radioisotopes | 2018 |
Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Rate; Uveal Neoplasms; Yttrium Radioisotopes | 2018 |
Unexpected ischemic complication after proximal coil embolization of a replaced left hepatic artery before yttrium-90 radioembolization.
Topics: Embolization, Therapeutic; Female; Hepatic Artery; Humans; Ischemia; Liver Neoplasms; Magnetic Resonance Imaging; Melanoma; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
Topics: Adult; Aged; Embolization, Therapeutic; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Melanoma; Middle Aged; Monte Carlo Method; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Melanoma; Microspheres; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Uveal Neoplasms; Young Adult; Yttrium Radioisotopes | 2016 |
Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.
Topics: Adult; Aged; Aged, 80 and over; Chicago; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Melanoma; Middle Aged; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.
Topics: Brachytherapy; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Hepatopulmonary shunt reduction with bland embolization for yttrium-90 radioembolization.
Topics: Arteriovenous Fistula; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Pulmonary Veins; Uveal Neoplasms; Yttrium Radioisotopes | 2016 |
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Eye Neoplasms; Hepatectomy; Humans; Length of Stay; Liver Neoplasms; Melanoma; Middle Aged; Neuroendocrine Tumors; Patient Readmission; Postoperative Complications; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2017 |
A first report of radioembolization for hepatic metastases from ocular melanoma.
Topics: Adult; Aged; Angiography, Digital Subtraction; Brachytherapy; Embolization, Therapeutic; Europe; Eye Neoplasms; Female; Hepatic Artery; Humans; Injections, Intra-Articular; Israel; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; United States; Yttrium Radioisotopes | 2009 |
Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.
Topics: alpha-MSH; Animals; Chelating Agents; Cyclization; Female; Gallium Radioisotopes; Indium Radioisotopes; Melanoma; Mice; Peptide Fragments; Positron-Emission Tomography; Receptor, Melanocortin, Type 1; Staining and Labeling; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2009 |
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.
Topics: Adult; Carcinoma, Adenosquamous; Cholangiocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Gastrinoma; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Microspheres; Middle Aged; Radiotherapy; Registries; Sarcoma; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cohort Studies; Disease-Free Survival; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Salvage Therapy; Sex Factors; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2013 |
Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues.
Topics: alpha-MSH; Animals; Kidney; Lutetium; Melanoma; Mice; Mice, Inbred C57BL; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Yttrium Radioisotopes | 2006 |
[Treatment of pains from bone metastases with 90Y (author's transl)].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Half-Life; Humans; Lung Neoplasms; Male; Melanoma; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Stomach Neoplasms; Yttrium Radioisotopes | 1981 |
[Results of beta-therapy of choroidal melanoma].
Topics: Choroid Neoplasms; Humans; Melanoma; Radiotherapy Dosage; Radiotherapy, High-Energy; Yttrium Radioisotopes | 1980 |
Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Colonic Neoplasms; Humans; Iodine Radioisotopes; Melanoma; Mice; Mice, Nude; Radioimmunodetection; Radioimmunotherapy; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 1993 |
Beta irradiation of conjunctival melanomas.
Topics: Adult; Conjunctiva; Eye Neoplasms; Female; Humans; Male; Melanoma; Middle Aged; Strontium Radioisotopes; Yttrium Radioisotopes | 1977 |
Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Dose-Response Relationship, Radiation; Glioma; Humans; Immunoenzyme Techniques; Male; Melanoma; Mice; Neoplasm Transplantation; Radiation Dosage; Radionuclide Imaging; Transplantation, Heterologous; Yttrium Radioisotopes | 1990 |